Insider Activity of Smith David Ross
The largest sale of all time was on 2021-02-19 and amounted to 8656 shares of Charles River Laboratories International, Inc. for $2.52M.
Biography of Smith David Ross
No biography is available at this moment.
The largest sale of all time was on 2021-02-19 and amounted to 8656 shares of Charles River Laboratories International, Inc. for $2.52M.
No biography is available at this moment.
2022-03-03 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 1,289 0.0025% | $283.41 | $365,316 | -20.28% | |
2021-08-09 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 1,750 0.0035% | $407.40 | $712,954 | -20.36% | |
2021-05-04 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 3,305 0.0066% | $340.01 | $1.12M | +6.55% | |
2021-04-22 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 3,845 0.0077% | $330.00 | $1.27M | +10.21% | |
2021-04-15 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 2,000 0.004% | $320.00 | $640,000 | +12.73% | |
2021-03-01 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 4,366 0.0088% | $290.12 | $1.27M | +24.7% | |
2021-02-19 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 8,656 0.0174% | $290.63 | $2.52M | +24.73% | |
2021-01-04 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 5,000 0.01% | $248.76 | $1.24M | +44.65% | |
2020-08-07 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 3,304 0.0065% | $216.54 | $715,444 | +24.82% | |
2020-05-07 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 1,884 0.0036% | $150.00 | $282,600 | +50.25% | |
2020-02-26 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 4,188 0.0086% | $162.26 | $679,535 | +34.78% | |
2020-02-24 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 8,211 0.0166% | $166.72 | $1.37M | +29.17% | |
2020-02-13 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 4,500 0.009% | $170.29 | $766,319 | +23.92% | |
2019-08-12 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 1,249 0.0026% | $130.36 | $162,821 | +13.13% | |
2019-02-27 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 2,158 0.0044% | $141.07 | $304,435 | -3.22% | |
2019-02-26 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 5,637 0.0116% | $140.25 | $790,594 | -1.94% | |
2019-02-25 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 8,210 0.0169% | $144.98 | $1.19M | -5.04% | |
2018-11-12 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 1,866 0.0039% | $134.49 | $250,961 | -1.08% | |
2018-08-13 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 1,249 0.0026% | $120.05 | $149,948 | +9.1% | |
2018-05-01 | Sale | Charles River Laboratories International, Inc. CRL | Corporate Executive VP & CFO | 945 0.0019% | $104.23 | $98,499 | +18.36% |